S, H., H, I., K, O., S, M., D, W., T, I., . . . A, S. (2023). Efficacy and safety of 5HT3RA, DEX, and NK1RA for the prevention of FOLFIRINOX-induced nausea and vomiting in patients with pancreatic cancer: A retrospective cohort study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 31(12), 657. https://doi.org/10.1007/s00520-023-08136-0
Chicago Style (17th ed.) CitationS, Hishida-Sadaka, Iihara H, Ohata K, Matsuoka S, Watanabe D, Iwashita T, Uemura S, Shimizu M, and Suzuki A. "Efficacy and Safety of 5HT3RA, DEX, and NK1RA for the Prevention of FOLFIRINOX-induced Nausea and Vomiting in Patients with Pancreatic Cancer: A Retrospective Cohort Study." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 31, no. 12 (2023): 657. https://doi.org/10.1007/s00520-023-08136-0.
MLA (9th ed.) CitationS, Hishida-Sadaka, et al. "Efficacy and Safety of 5HT3RA, DEX, and NK1RA for the Prevention of FOLFIRINOX-induced Nausea and Vomiting in Patients with Pancreatic Cancer: A Retrospective Cohort Study." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, vol. 31, no. 12, 2023, p. 657, https://doi.org/10.1007/s00520-023-08136-0.
